Compliance a kvalita života u pacientů s antikoagulační léčbou: první výsledky pilotní studie
Open Access
- 31 January 2021
- journal article
- Published by Palacky University Olomouc in Profese online
- Vol. 13 (2), 36-45
- https://doi.org/10.5507/pol.2020.017
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherenceEP Europace, 2015
- Identification and Management of Noncompliance in Atrial Fibrillation Patients Receiving Dabigatran: The Role of a Drug MonitorPacing and Clinical Electrophysiology, 2015
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort studyJournal of Thrombosis and Haemostasis, 2015
- European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Summary of the document prepared by the Czech Society of CardiologyCor et Vasa, 2014
- Adherence to anticoagulant treatment with dabigatran in a real‐world settingJournal of Thrombosis and Haemostasis, 2013
- Adherence and outcomes of patients treated with dabigatran: Pharmacist-managed anticoagulation clinic versus usual careAmerican Journal of Health-System Pharmacy, 2013
- Dabigatran for Anticoagulation in Atrial Fibrillation – Early Clinical Experience in a Hospital Population and Comparison to Trial DataHeart, Lung and Circulation, 2013
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialThe Lancet, 2010
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986